PL3042199T3 - Sposoby i zestawy do określania stanu zakażenia gruźlicą - Google Patents

Sposoby i zestawy do określania stanu zakażenia gruźlicą

Info

Publication number
PL3042199T3
PL3042199T3 PL14789334T PL14789334T PL3042199T3 PL 3042199 T3 PL3042199 T3 PL 3042199T3 PL 14789334 T PL14789334 T PL 14789334T PL 14789334 T PL14789334 T PL 14789334T PL 3042199 T3 PL3042199 T3 PL 3042199T3
Authority
PL
Poland
Prior art keywords
kits
methods
tuberculosis infection
infection status
determining tuberculosis
Prior art date
Application number
PL14789334T
Other languages
English (en)
Inventor
Ajit Lalvani
Katrina Mary Pollock
Graham Taylor
Hilary Sian Whitworth
Original Assignee
Mjo Innovation Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mjo Innovation Limited filed Critical Mjo Innovation Limited
Publication of PL3042199T3 publication Critical patent/PL3042199T3/pl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G01N33/505—Cells of the immune system involving T-cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/5695—Mycobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/35—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Mycobacteriaceae (F)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/525—Tumor necrosis factor [TNF]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/555—Interferons [IFN]
    • G01N2333/57—IFN-gamma
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
    • G01N2333/70514—CD4
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
    • G01N2333/70517—CD8
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70589—CD45
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/26—Infectious diseases, e.g. generalised sepsis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
PL14789334T 2013-09-04 2014-09-04 Sposoby i zestawy do określania stanu zakażenia gruźlicą PL3042199T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1315748.2A GB201315748D0 (en) 2013-09-04 2013-09-04 Biological methods and materials for use therein
EP14789334.1A EP3042199B1 (en) 2013-09-04 2014-09-04 Methods and kits for determining tuberculosis infection status
PCT/GB2014/052667 WO2015033136A1 (en) 2013-09-04 2014-09-04 Methods and kits for determining tuberculosis infection status

Publications (1)

Publication Number Publication Date
PL3042199T3 true PL3042199T3 (pl) 2018-07-31

Family

ID=49397285

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14789334T PL3042199T3 (pl) 2013-09-04 2014-09-04 Sposoby i zestawy do określania stanu zakażenia gruźlicą

Country Status (12)

Country Link
US (3) US10041944B2 (pl)
EP (1) EP3042199B1 (pl)
CY (1) CY1120220T1 (pl)
DK (1) DK3042199T3 (pl)
ES (1) ES2665605T3 (pl)
GB (1) GB201315748D0 (pl)
HU (1) HUE038739T2 (pl)
LT (1) LT3042199T (pl)
NO (1) NO3042199T3 (pl)
PL (1) PL3042199T3 (pl)
PT (1) PT3042199T (pl)
WO (1) WO2015033136A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201315748D0 (en) 2013-09-04 2013-10-16 Imp Innovations Ltd Biological methods and materials for use therein
CN107202882B (zh) * 2016-03-17 2019-02-22 广东体必康生物科技有限公司 Rv0440蛋白在诊断潜伏性/活动性肺结核中的用途
EP3555630B1 (en) * 2016-12-14 2023-05-31 Becton, Dickinson and Company Methods and compositions for obtaining a tuberculosis assessment in a subject
JOP20190187A1 (ar) 2017-02-03 2019-08-01 Novartis Ag مترافقات عقار جسم مضاد لـ ccr7
WO2018223151A1 (en) * 2017-06-03 2018-12-06 Flowmetric Life Sciences, Inc. Flow cytometry system and methods for the diagnosis of infectious disease
CN111337681A (zh) * 2020-03-20 2020-06-26 上海东方肝胆外科医院 评估肝细胞癌预后的标志物、试剂盒及方法
WO2023170189A1 (en) * 2022-03-09 2023-09-14 Fundacio Privada Institut De Recerca De La Sida-Caixa Boosted immune monitoring methods for assaying antigen-specific t cell responses

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7364869B2 (en) * 2003-07-29 2008-04-29 The J. David Gladstone Institutes Method of detecting antigen-specific T lymphocytes
ITRM20040091A1 (it) 2004-02-19 2004-05-19 Istituto Naz Per Le Malattie Test immunologico rapido per la diagnosi ed il monitoraggio dell'infezione tubercolare.
EP1794187A4 (en) 2004-08-19 2008-03-26 Proteome Systems Intellectual METHOD FOR THE DIAGNOSIS AND TREATMENT OF A M.TUBERCULOSIS INFECTION AND REAGENTS THEREFOR
JP5017269B2 (ja) 2005-07-26 2012-09-05 ユニヴァーシティ オブ メディシン アンド デンティストリ オブ ニュージャーシィ 結核状態に特有の抗体プロフィール
EP1996732A4 (en) 2006-03-02 2010-03-31 Uab Research Foundation RECOGNITION AND TREATMENT AND DISCOVERY OF REMEDIES AGAINST MYCOBACTERIAL DISEASES
GB0605474D0 (en) 2006-03-17 2006-04-26 Isis Innovation Clinical correlates
GB0708874D0 (en) 2007-05-08 2007-06-13 Univ The Of Birmingham Assay for detecting mycrobacterial infection
EP2197908A2 (en) 2007-09-27 2010-06-23 Dako Denmark A/S Mhc multimers in tuberculosis diagnostics, vaccine and therapeutics
DE102007052518A1 (de) 2007-10-29 2009-04-30 Autoimmun Diagnostika Gmbh Verfahren zur in vitro-Diagnose und/oder in vitro- Therapieverfolgung von Infektionen
US20110268744A1 (en) 2008-05-26 2011-11-03 Ian Garthwaite Method of Diagnosis of Infection by Mycobacteria and Reagents Therefor
MX2010014556A (es) 2008-06-25 2011-07-28 Baylor Res Inst Firma transcripcional de sangre por infeccion de mycobacterium tuberculosis.
US20110129817A1 (en) 2009-11-30 2011-06-02 Baylor Research Institute Blood transcriptional signature of active versus latent mycobacterium tuberculosis infection
AP2011005772A0 (en) 2008-12-15 2011-06-30 Univ Cape Town Method and device for diagnosing tuberculosis.
US20130018178A1 (en) 2009-06-22 2013-01-17 Px Therapeutics Method for the purification of hbha
US8058022B2 (en) 2009-07-27 2011-11-15 Indian Institute Of Science Diagnosis and monitoring of mycobacterium tuberculosis infection
US20110070599A1 (en) 2009-09-18 2011-03-24 Becton, Dickinson And Company Method for Screening of Active Tuberculosis
WO2011044508A1 (en) 2009-10-08 2011-04-14 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Biomarkers for prognoses of pulmonary diseases
EP2548019A1 (en) 2010-03-19 2013-01-23 Red Flag Diagnostics GmbH In vitro process for the quick determination of a patient's status relating to infection with mycobacterium tuberculosis
EP2655662A2 (en) 2010-12-23 2013-10-30 Centre Hospitalier Universitaire Vaudois Lausanne (CHUV) Methods for differentiating between disease states
CA2863236A1 (en) 2012-01-31 2013-08-08 Advanced Medical Research Institute Of Canada Methods of determining cell mediated response
WO2014039044A1 (en) 2012-09-06 2014-03-13 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods of producing t memory stem cell populations
GB201315748D0 (en) * 2013-09-04 2013-10-16 Imp Innovations Ltd Biological methods and materials for use therein

Also Published As

Publication number Publication date
DK3042199T3 (en) 2018-04-23
US20180313835A1 (en) 2018-11-01
EP3042199B1 (en) 2018-01-10
US20160195529A1 (en) 2016-07-07
PT3042199T (pt) 2018-04-17
US10883990B2 (en) 2021-01-05
LT3042199T (lt) 2018-06-11
NO3042199T3 (pl) 2018-06-09
ES2665605T3 (es) 2018-04-26
US11204352B2 (en) 2021-12-21
CY1120220T1 (el) 2018-12-12
HUE038739T2 (hu) 2018-11-28
US10041944B2 (en) 2018-08-07
WO2015033136A1 (en) 2015-03-12
GB201315748D0 (en) 2013-10-16
EP3042199A1 (en) 2016-07-13
US20210164979A1 (en) 2021-06-03

Similar Documents

Publication Publication Date Title
IL244394A0 (en) Systems and methods for diagnosing infectious diseases
GB2534093B (en) Systems and methods for improved accuracy
EP2923791A4 (en) MACHINING DEVICE AND PROCESSING METHOD
EP2970340A4 (en) BETA-Lactamase INHIBITORS
EP2943204A4 (en) BETA-Lactamase INHIBITORS
HK1218576A1 (zh) 結核病生物標誌物及其用途
EP2951662A4 (en) SYSTEM AND METHOD FOR USER MONITORING AND DETERMINING INTENT
EP2962801A4 (en) MACHINING DEVICE AND METHOD
PL3042199T3 (pl) Sposoby i zestawy do określania stanu zakażenia gruźlicą
EP2960669A4 (en) MAGNETA EVALUATION DEVICE AND METHOD
EP2985621A4 (en) Magnetic property determination device and magnetic property determination method
HK1224171A1 (zh) 移動輔助裝置和相關聯的方法
EP2960933A4 (en) SAMPLE HOLDER TOOL
HK1222683A1 (zh) 用於檢測藥物性耳聾易感性的試劑盒及方法
GB201312318D0 (en) Novel methods and compounds
EP3800259C0 (en) AXMI486 TOXIN GENE AND METHOD OF USE THEREOF
PT3006595T (pt) Dispositivo de deposição e método de deposição utilizando o mesmo
EP3007466A4 (en) Acoustic device and use method thereof
HK1202941A1 (en) Method for locating block and device thereof
GB201604534D0 (en) Nucleic-acid-sequence determination device and nucleic-acid-sequence determination method
EP3018469A4 (en) State determination method and state determination device
IL246403A0 (en) Methods and reagents for radioactive labeling
GB201308596D0 (en) Balancing method
PT2821771T (pt) Método de teste
EP2968707A4 (en) FLUID ANALYZER AND ASSOCIATED METHODS